T36.1X5 Category · further specificity required Adverse effect of cephalosporins and other beta-lactam antibiotics

ICD-10-CM T36.1X5 identifies “Adverse effect of cephalosporins and other beta-lactam antibiotics” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Chapter 19: Injury, poisoning and certain other consequences of external causes

Code-level instructions

No additional notes.

Inherited instructions

Chapters 19 · Injury, poisoning and certain other consequences of external causes (S00-T88)

Excludes 22
  • birth trauma (P10-P15)
  • obstetric trauma (O70-O71)
Use additional code1

code to identify any retained foreign body, if applicable (Z18.-)

Note2
  • Use secondary code(s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code
  • The chapter uses the S-section for coding different types of injuries related to single body regions and the T-section to cover injuries to unspecified body regions as well as poisoning and certain other consequences of external causes.

T36-T50 · Poisoning by, adverse effects of and underdosing of drugs, medicaments and biological substances (T36-T50)

Includes4
  • adverse effect of correct substance properly administered
  • poisoning by overdose of substance
  • poisoning by wrong substance given or taken in error
  • underdosing by (inadvertently) (deliberately) taking less substance than prescribed or instructed
Excludes 11

toxic reaction to local anesthesia in pregnancy (O29.3-)

Excludes 25
  • abuse and dependence of psychoactive substances (F10-F19)
  • abuse of non-dependence-producing substances (F55.-)
  • immunodeficiency due to drugs (D84.821)
  • drug reaction and poisoning affecting newborn (P00-P96)
  • pathological drug intoxication (inebriation) (F10-F19)
Code first7
  • , for adverse effects, the nature of the adverse effect, such as:
  • adverse effect NOS (T88.7)
  • aspirin gastritis (K29.-)
  • blood disorders (D56-D76)
  • contact dermatitis (L23-L25)
  • dermatitis due to substances taken internally (L27.-)
  • nephropathy (N14.0-N14.2)
Use additional code4
  • code(s) to specify:
  • manifestations of poisoning
  • underdosing or failure in dosage during medical and surgical care (Y63.6, Y63.8-Y63.9)
  • underdosing of medication regimen (Z91.12-, Z91.13-)
Note1

The drug giving rise to the adverse effect should be identified by use of codes from categories T36-T50 with fifth or sixth character 5.

T36 · Poisoning by, adverse effect of and underdosing of systemic antibiotics

Excludes 14
  • antineoplastic antibiotics (T45.1-)
  • locally applied antibiotic NEC (T49.0)
  • topically used antibiotic for ear, nose and throat (T49.6)
  • topically used antibiotic for eye (T49.5)
Seventh character1

The appropriate 7th character is to be added to each code from category T36

A — initial encounter

D — subsequent encounter

S — sequela

More specific codes

Official index references

Official index references (52)

Antibiotic NEC (2)
Aztreonam (1)
Cefacetrile (1)
Cefaclor (1)
Cefadroxil (1)
Cefalexin (1)
Cefaloglycin (1)
Cefaloridine (1)
Cefalosporins (1)
Cefalotin (1)
Cefamandole (1)
Cefamycin antibiotic (1)
Cefapirin (1)
Cefatrizine (1)
Cefazedone (1)
Cefazolin (1)
Cefbuperazone (1)
Cefetamet (1)
Cefixime (1)
Cefmenoxime (1)
Cefmetazole (1)
Cefminox (1)
Cefonicid (1)
Cefoperazone (1)
Ceforanide (1)
Cefotaxime (1)
Cefotetan (1)
Cefotiam (1)
Cefoxitin (1)
Cefpimizole (1)
Cefpiramide (1)
Cefradine (1)
Cefroxadine (1)
Cefsulodin (1)
Ceftazidime (1)
Cefteram (1)
Ceftezole (1)
Ceftizoxime (1)
Ceftriaxone (1)
Cefuroxime (1)
Cefuzonam (1)
Cephalexin (1)
Cephaloglycin (1)
Cephaloridine (1)
Cephalosporins (1)
Cephalothin (1)
Cephalotin (1)
Cephradine (1)
Clavulanic acid (1)
Flomoxef (1)
Latamoxef (1)
History

Code history

Latest recorded change · FY2025 · 04-01

ChangedUnchanged
FY2025 · 04-01

Effective from

  • Inherited rules changed

Adverse effect of cephalosporins and other beta-lactam antibiotics

Category — select a more specific code

CDC/NCHS · FY2025 · 04-01

All editions (19)

All editionsEffective fromCode history
FY20162015-10-01First observed
FY20172016-10-01No tabular change
FY20182017-10-01No tabular change
FY20192018-10-01Inherited rules changed
FY20202019-10-01No tabular change
FY2020 · April2020-04-01No tabular change
FY20212020-10-01Inherited rules changed
FY2021 · 01-012021-01-01No tabular change
FY20222021-10-01No tabular change
FY2022 · 04-012022-04-01No tabular change
FY20232022-10-01No tabular change
FY2023 · 04-012023-04-01No tabular change
FY20242023-10-01No tabular change
FY2024 · 04-012024-04-01No tabular change
FY20252024-10-01No tabular change
FY2025 · 04-012025-04-01Inherited rules changed
FY20262025-10-01No tabular change
FY2026 · April2026-04-01No tabular change
FY20272026-10-01No tabular change

Explore the more specific codes in this category. Reference checks do not establish clinical appropriateness or guarantee reimbursement.